Article metrics

Download PDFPDF

POS1042 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, COMPARED WITH PLACEBO AND APREMILAST IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM THE PHASE 3 POETYK PSO-1 STUDY
Free

 

Online download statistics by month:

Online download statistics by month: May 2021 to January 2024

AbstractFullPdf
May 202140020
Jun 202134074
Jul 202119094
Aug 2021160118
Sep 2021200113
Oct 202113530185
Nov 202110420154
Dec 202110180112
Jan 20228560124
Feb 202210220132
Mar 202215020249
Apr 202213690212
May 202214050184
Jun 202217180212
Jul 202212990171
Aug 202215580191
Sep 202226930235
Oct 202216250173
Nov 20221075082
Dec 2022644071
Jan 2023676063
Feb 2023611054
Mar 2023673082
Apr 2023338032
May 2023417066
Jun 2023403036
Jul 2023561041
Aug 2023380038
Sep 2023379032
Oct 2023448035
Nov 2023412048
Dec 2023284029
Jan 202413005
Total2602003467